Psychedelic NewsJanuary 4, 2026 Psychedelic Sector Week in Review: December 29, 2025 – January 4, 2026
PressDecember 11, 2025 AtaiBeckley granted new U.S. patent for oral R-MDMA candidate EMP-01, extending exclusivity to 2043
PressDecember 10, 2025 PharmAla completes release testing on first Australian-made LaNeo MDMA capsules
PressDecember 5, 2025 New Mexico's Medical Psilocybin Advisory Board convenes, eyes accelerated launch
PressDecember 4, 2025 Bipartisan 'Freedom to Heal Act' would open Right to Try access to psilocybin and MDMA
PressDecember 2, 2025 FDA accepts NRx's ANDA for preservative-free IV ketamine KETAFREE with July 2026 goal date
PressDecember 1, 2025 Numinus provides corporate update amid TSX delisting review and auditor turnover
PressNovember 26, 2025 Optimi Health selected to supply MDMA for MAPS Israel's 168-patient PTSD trial
PressNovember 18, 2025 MindMed presents at Jefferies Global Healthcare Conference amid MM120 Phase 3 push
PressNovember 17, 2025 Bright Minds expands scientific advisory board to support BMB-101 and new Prader-Willi program
